基本信息
views: 342
Career Trajectory
Bio
Dr. Myers leads a basic and translational research program and his primary research interests are in the role of p53 mutation in oral cancer progression, metastasis and response to treatment.
The goal of our laboratory is to understand the role of oncogenic mutations in promoting tumorigenesis and progression of head and neck cancers, and to exploit this knowledge to develop effective targeted therapies for head and neck cancer patients.
Specifically, the research group focuses on large-scale analyses of genomic and epigenetic alterations in head and neck cancers and understanding the functional mechanisms of gain-of-function TP53 mutations in the promotion of chromosomal instability, metastasis, and cancer metabolism of head and neck cancers.
The Myers laboratory also focuses on understanding the functional roles of TP53 mutations in the development of tumor immunosuppressive microenvironment that promotes immunoevasion and immunotherapy resistance of head and neck cancers. Additionally, we have established genetically engineered mouse models (GEMMs) in oral cancer, which allows us to study tumor immunity at different carcinogenic stages and identify novel therapeutic targets. Moreover, we are developing alternative approaches to drug delivery of immunotherapeutic agents in order to improve response and avoid systemic toxicity. Ultimately, unraveling these mechanisms can better guide the development of new therapies.
The goal of our laboratory is to understand the role of oncogenic mutations in promoting tumorigenesis and progression of head and neck cancers, and to exploit this knowledge to develop effective targeted therapies for head and neck cancer patients.
Specifically, the research group focuses on large-scale analyses of genomic and epigenetic alterations in head and neck cancers and understanding the functional mechanisms of gain-of-function TP53 mutations in the promotion of chromosomal instability, metastasis, and cancer metabolism of head and neck cancers.
The Myers laboratory also focuses on understanding the functional roles of TP53 mutations in the development of tumor immunosuppressive microenvironment that promotes immunoevasion and immunotherapy resistance of head and neck cancers. Additionally, we have established genetically engineered mouse models (GEMMs) in oral cancer, which allows us to study tumor immunity at different carcinogenic stages and identify novel therapeutic targets. Moreover, we are developing alternative approaches to drug delivery of immunotherapeutic agents in order to improve response and avoid systemic toxicity. Ultimately, unraveling these mechanisms can better guide the development of new therapies.
Research Interests
Papers共 711 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Brady J. Anderson,Amy C. Moreno,Yun Qing,J. Jack Lee,Faye M. Johnson,Miriam N. Lango,Carly E. A. Barbon, Lavanya Tripuraneni, Ariana Sahli, Vicki Piper,Neil Gross,Clifton D. Fuller,Stephen Y. Lai,Jeffrey N. Myers,Katherine A. Hutcheson
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgeryno. 5 (2024): 1319-1330
Journal of immunotherapy and precision oncologyno. 1 (2024): 24-40
European journal of cancer (Oxford, England 1990) (2024): 113983-113983
Seminars in ophthalmologypp.1-7, (2024)
Cancer Researchno. 7_Supplement (2023): 619-619
openalex(2023)
Abdullah A. Osman, Fabio H. B. da Costa,Adewale A. Adebayo,Mason D. Bartels,Tongxin Xie,Moran Amit, Mutsuki Kawabe,Roberto Rangel,Mitchell J. Frederick,Vlad Sandulache,Andrew G. Sikora,Jeffrey N. Myers
CLINICAL CANCER RESEARCHno. 18 (2023): PO-085
Load More
Author Statistics
#Papers: 712
#Citation: 47635
H-Index: 97
G-Index: 208
Sociability: 8
Diversity: 3
Activity: 389
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn